These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17425462)

  • 1. Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
    Pardo M; Dwek RA; Zitzmann N
    Expert Rev Proteomics; 2007 Apr; 4(2):273-86. PubMed ID: 17425462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
    Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
    Proteomics; 2005 Dec; 5(18):4980-93. PubMed ID: 16267820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in uveal melanoma.
    Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
    Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
    Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
    Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics of liver metastases from uveal melanoma.
    Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
    Kujala E; Tuomaala S; Eskelin S; Kivelä T
    Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.
    Pardo M; García A; Antrobus R; Blanco MJ; Dwek RA; Zitzmann N
    J Proteome Res; 2007 Jul; 6(7):2802-11. PubMed ID: 17539671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct tissue proteomics in human diseases: potential applications to melanoma research.
    Rezaul K; Wilson LL; Han DK
    Expert Rev Proteomics; 2008 Jun; 5(3):405-12. PubMed ID: 18532908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T; Carbone DP
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.